Lantern Pharma Inc.
LTRN
Revenue
0.00
0.000.00%
-Assets
35.59M
▼-4.15M▼-10.44%
3 Months ChangeLiabilities
4.66M
▲686.49k▲17.30%
3 Months ChangeFree Cash Flow
-3.07M
▲695.29k▲18.46%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0001493152-24-030766
2024-08-08
Form 8-K
ID: 0001493152-24-030764
2024-06-17
Form 8-K
ID: 0001493152-24-024110
2024-05-24
Form 8-K
ID: 0001493152-24-021353
2024-05-09
Form 10-Q
ID: 0001493152-24-018422
2024-05-09
Form 8-K
ID: 0001493152-24-018426
2024-03-18
Form 8-K
ID: 0001493152-24-010303
2023-12-29
Form 8-K
ID: 0001493152-23-046572
2023-11-24
Form 8-K
ID: 0001493152-23-042670
2023-11-08
Form 10-Q
ID: 0001493152-23-039896